Poland· PL-100409921
Esogno
A eszopiclone product containing eszopiclonum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Eszopiclone is registered in 10 of 19 countries.
Countries holding a registration under ATC N05CF04 (eszopiclone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Eszopiclone · ATC N05CF04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Japan
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eszopiclone costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eszopiclone · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- FR France$0.13
The record
At a glance
URPL (Poland)- Active substance
- Eszopiclonum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N05CF04
- ATC class
- Eszopiclone
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin09008732011760
- gtin09008732011777
- gtin09008732011784
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
126 interactions on record for eszopiclone.
Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eszopiclone · interactions on record
126 records
- 13 severe
- 113 moderate
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eszopiclone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaESOGNOG.L. Pharma GmbH, Lannach
- United StatesEszopicloneNuCarePharmaceuticals, Inc.
- BelgiumEsnoxiben 3 mgAlfred E. Tiefenbacher
- FinlandLuniviaAlfred E. Tiefenbacher (GmbH & Co. KG)
- FranceNOXIBEN 3 mg, comprimé pelliculéG.L. PHARMA (AUTRICHE)
- CanadaLUNESTASUMITOMO PHARMA CANADA, INC.
- United KingdomLunivia 1mg tabletsAxunio Pharma GmbH
- GermanyEsognoG.L. Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Esogno
- Bulgaria · Есогно
- Czechia · Esogno
- Germany · Esogno, Lunivia
- Estonia · Esogno
- France · Noxiben
- Hungary · Esogno
- Italy · Esnoxiben
- Lithuania · Esogno
- Latvia · Esogno
- Slovakia · Esogno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8db11e3-34ee-478f-a9b5-c6ea1bc9994f GET /v1/drugs/e8db11e3-34ee-478f-a9b5-c6ea1bc9994f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "3 mg",
"packaging": "09008732011760 ¦ Rp ¦ 135725\n7 tabl.\n09008732011777 ¦ Rp ¦ 135726\n14 tabl.\n09008732011784 ¦ Rp ¦ 135727\n28 tabl.",
"substance": "Eszopiclonum 3 mg",
"common_name": "Eszopiclonum",
"pl_product_id": "100409921",
"pozwolenie_nr": "25902",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about eszopiclone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.